类风湿关节炎的早期积极治疗：一个“机会窗口”？ - Suppr

Early aggressive therapy in rheumatoid arthritis: a 'window of opportunity'?

作者信息

Huizinga Tom W J, Landewé Robert B M

机构信息

Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands.

出版信息

Nat Clin Pract Rheumatol. 2005 Nov;1(1):2-3. doi: 10.1038/ncprheum0015.

DOI:10.1038/ncprheum0015

PMID:16932617

Abstract

摘要

相似文献

Early aggressive therapy in rheumatoid arthritis: a 'window of opportunity'?

Nat Clin Pract Rheumatol. 2005 Nov;1(1):2-3. doi: 10.1038/ncprheum0015.

Early rheumatoid arthritis -- is there a window of opportunity?

J Rheumatol Suppl. 2007 Nov;80:1-7.

Timing the therapeutic window of opportunity in early rheumatoid arthritis: proposal for definitions of disease duration in clinical trials.

Ann Rheum Dis. 2012 Dec;71(12):1921-3. doi: 10.1136/annrheumdis-2012-201893. Epub 2012 Aug 31.

Potential for altering rheumatoid arthritis outcome.

Rheum Dis Clin North Am. 2005 Nov;31(4):763-72. doi: 10.1016/j.rdc.2005.07.008.

[Early therapy -- later retirement].

MMW Fortschr Med. 2004 Sep 9;146(37):6, 8.

Are biologics more effective than classical disease-modifying antirheumatic drugs?

Arthritis Res Ther. 2008;10(5):118. doi: 10.1186/ar2491. Epub 2008 Sep 19.

Reduction of serum interleukin 7 levels upon methotrexate therapy in early rheumatoid arthritis correlates with disease suppression.

Ann Rheum Dis. 2008 Jul;67(7):1054-5. doi: 10.1136/ard.2007.081059.

Tailor-made therapy in rheumatoid arthritis: fact or fiction?

Isr Med Assoc J. 2008 Feb;10(2):139-41.

Understanding the window of opportunity concept in early rheumatoid arthritis.

Arthritis Rheum. 2003 Jul;48(7):1771-4. doi: 10.1002/art.11156.

Do all drugs and treatments for rheumatoid arthritis have the same efficacy?

Nat Clin Pract Rheumatol. 2008 Jun;4(6):298-9. doi: 10.1038/ncprheum0806. Epub 2008 Apr 22.

引用本文的文献

Global, regional and national disparities and temporal trends of common autoimmune disease burdens among children and adolescents from 1990 to 2019.

BMJ Glob Health. 2025 Apr 3;10(4):e017187. doi: 10.1136/bmjgh-2024-017187.

A 9 mRNAs-based diagnostic signature for rheumatoid arthritis by integrating bioinformatic analysis and machine-learning.

J Orthop Surg Res. 2021 Jan 11;16(1):44. doi: 10.1186/s13018-020-02180-w.

GlycA Levels during the Earliest Stages of Rheumatoid Arthritis: Potential Use as a Biomarker of Subclinical Cardiovascular Disease.

J Clin Med. 2020 Aug 1;9(8):2472. doi: 10.3390/jcm9082472.

Comparative effectiveness research with administrative health data in rheumatoid arthritis.

Nat Rev Rheumatol. 2016 Jun;12(6):358-66. doi: 10.1038/nrrheum.2016.34. Epub 2016 Apr 15.

Visualizing arthritic inflammation and therapeutic response by fluorine-19 magnetic resonance imaging (19F MRI).

J Inflamm (Lond). 2012 Jun 21;9(1):24. doi: 10.1186/1476-9255-9-24.

Looking through the 'window of opportunity': is there a new paradigm of podiatry care on the horizon in early rheumatoid arthritis?

J Foot Ankle Res. 2010 May 17;3:8. doi: 10.1186/1757-1146-3-8.

Benefit of early treatment in inflammatory polyarthritis patients with anti-cyclic citrullinated peptide antibodies versus those without antibodies.

Arthritis Care Res (Hoboken). 2010 May;62(5):664-75. doi: 10.1002/acr.20207.

Antibodies to citrullinated vimentin are a specific and sensitive marker for the diagnosis of rheumatoid arthritis.

Clin Rev Allergy Immunol. 2008 Feb;34(1):4-10. doi: 10.1007/s12016-007-8016-3.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Early aggressive therapy in rheumatoid arthritis: a 'window of opportunity'?

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献